New program tackles smoking in HIV by easing anxiety and depression
NCT ID NCT03904186
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a 9-session program that uses cognitive-behavioral techniques to help people living with HIV quit smoking by reducing anxiety and depression. 131 daily smokers who were motivated to quit took part. The goal was to see if the program led to more people staying smoke-free at 1 month and 6 months after quitting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fenway Community Health
Boston, Massachusetts, 02215, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Thomas Street Health Center
Houston, Texas, 77009, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Can a Two-Drug combo break the smoking habit?
- Virtual reality may distract patients from pain and fear during anesthesia
- Personalized nicotine patch dosing may boost quit rates